Compuestos y reactivos bioquímicos
Subcategorías de "Compuestos y reactivos bioquímicos"
- Biomoléculas(98.575 productos)
- Por objetivo biológico(100.710 productos)
- Según efectos farmacológicos(6.937 productos)
- Crioconservantes(21 productos)
- Desinfectantes y compuestos relacionados(28 productos)
- Hormonas(421 productos)
- Biología Vegetal(6.907 productos)
- Metabolitos secundarios(14.367 productos)
Se han encontrado 130493 productos de "Compuestos y reactivos bioquímicos"
CGRP (Human, 8-37)
CAS:CGRP (Human, 8-37) is a peptide derived from the calcitonin gene-related peptide (CGRP) that is found in the nervous system and other tissues in humans. It is a truncated form of the full-length CGRP peptide, consisting of the last 30 amino acids of the CGRP sequence (amino acids 8-37).
CGRP is a potent vasodilator and plays a key role in regulating blood flow and blood pressure. It is also involved in pain perception, inflammation, and neurogenic inflammation. CGRP (Human, 8-37) is an antagonist of CGRP, meaning that it binds to the CGRP receptor without activating it, thereby blocking the effects of CGRP.
CGRP (Human, 8-37) has been used as a research tool to study the physiological and pathological roles of CGRP in various tissues and diseases, such as migraine headaches, cardiovascular diseases, and inflammatory disorders. It has also been investigated as a potential therapeutic agent for these conditions, as well as for the treatment of pain and other neurological disorders.
This product is available as a 0.5mg vial.Fórmula:C139H230N44O38Pureza:Min. 95%Peso molecular:3,125.6 g/molBMS 509744
CAS:BMS 509744 is a tyrosine kinase inhibitor. It inhibits the activation of the signal pathways that are involved in the proliferation of t-cells. BMS 509744 has been shown to be effective in inhibiting cancer cells, with a particular focus on T-cell lymphomas. The drug also inhibits inflammation by inhibiting toll-like receptor. This drug has been shown to have an effective dose of 10mg in animal studies and is currently undergoing clinical trials for use against inflammatory diseases, such as rheumatoid arthritis and psoriasis.
Fórmula:C32H41N5O4S2Pureza:Min. 95%Peso molecular:623.83 g/molRef: 3D-PSA57502
Producto descatalogadoDAZAP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DAZAP1 antibody, catalog no. 70R-1356
Pureza:Min. 95%MYBPH Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MYBPH antibody, catalog no. 70R-6049
Pureza:Min. 95%RBMY1A1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RBMY1A1 antibody, catalog no. 70R-4807
Pureza:Min. 95%ERCC4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ERCC4 antibody, catalog no. 70R-2117
Pureza:Min. 95%NDST4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NDST4 antibody, catalog no. 70R-7270
Pureza:Min. 95%Rat Thrombocyte antibody
Rat thrombocyte antibody was raised in rabbit using rat thrombocytes as the immunogen.
Pureza:Min. 95%[D-Trp8]-Somatostatin
CAS:This product contains disulfide bonds between Cys3-Cys14. Somatostatin is a hormone that regulates the release of growth hormones, insulin, and glucagon from the pancreas. It is widely expressed throughout the body for example in the gastrointestinal (GI) tract, hypothalamus, pancreas and the central nervous system. In the central nervous system somatostatin plays a role in neurotransmission modification and it has also demonstrated to be effective against a number of cancers such as squamous carcinoma.
Fórmula:C76H104N18O19S2Pureza:Min. 95%Peso molecular:1,637.9 g/molCytokeratin 8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KRT8 antibody, catalog no. 70R-3263
Pureza:Min. 95%FAIM Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FAIM antibody, catalog no. 70R-3010
Pureza:Min. 95%Margatoxin
CAS:Margatoxin is a research tool that has been shown to activate the nicotinic acetylcholine receptor. It binds to the ligand-binding site of the receptor and blocks ion channel activity. Margatoxin is a small molecule with high purity that can be used as a tool to study protein interactions and biological functions. This compound is also an inhibitor of peptide binding, which can be used in pharmacology studies.
Fórmula:C178H286N52O50S7Pureza:Min. 95%Peso molecular:4,178.9 g/molCDYL Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CDYL antibody, catalog no. 70R-2099
Pureza:Min. 95%PTPN2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PTPN2 antibody, catalog no. 70R-6996
Pureza:Min. 95%Avidin-HRP
Avidin-HRP is a versatile chemokine that is widely used in the field of Life Sciences. It is a lectin that can bind to various molecules and has been extensively studied for its applications in research and diagnostics. Avidin-HRP is commonly used in immunoassays, where it acts as an electrode to detect the presence of specific molecules. It can also be used as a blocker or diluent in assays to prevent non-specific binding and enhance the accuracy of results.Pureza:Min. 95%MCD-Peptide
CAS:A synthetic voltage-dependent K+ channel blocker derived from bee venom. This product is sourced from the Honeybee, Apis mellifera and has disulfide bonds between Cys3-Cys15 and Cys5-Cys19.
Available as a 0.5mg vial.Fórmula:C110H192N40O24S4Pureza:Min. 95%Peso molecular:2,587.2 g/molGSK3beta antibody
GSK3beta antibody was raised in mouse using recombinant human GSk3 beta (341-420aa) purified from E. coli as the immunogen.
DCUN1D1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DCUN1D1 antibody, catalog no. 70R-3479
Pureza:Min. 95%
